A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Clinical trial NCT04426669 · COMPLETED

Trial details

NCT number: NCT04426669
Sponsor: Intima Bioscience, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Epithelial Cancer Gastrointestinal Neoplasms Cancer of Gastrointestinal Tract Cancer, Gastrointestinal Gastrointestinal Cancer Colo-rectal Cancer Pancreatic Cancer Gall Bladder Cancer Colon Cancer Esophageal Cancer Stomach Cancer

Start date: 2020-05-15
Primary completion: 2025-05-28
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.